MindImmune Therapeutics Announces $12.4 million Series A Financing



Comments are closed.

Tetra Therapeutics announces positive topline results from Phase 2 study of BPN14770 in patients with Fragile X Syndrome
AltspaceVR Announces $2.5 Million Seed Round
Cortexyme Completes $76 Million Series B Financing
Keyssa on EE Times’ 60 Startups to Watch List